| Year |
Citation |
Score |
| 2023 |
Domblides C, Alizadeh D, Larmonier N. Editorial: Tumor-promoting immune cells: Cancer immune escape and beyond. Frontiers in Immunology. 14: 1168884. PMID 36936910 DOI: 10.3389/fimmu.2023.1168884 |
0.436 |
|
| 2022 |
Blaye C, Boyer T, Peyraud F, Domblides C, Larmonier N. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers. Frontiers in Immunology. 13: 838040. PMID 35309358 DOI: 10.3389/fimmu.2022.838040 |
0.395 |
|
| 2022 |
Boyer T, Blaye C, Larmonier N, Domblides C. Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives. Cells. 11. PMID 35159363 DOI: 10.3390/cells11030554 |
0.413 |
|
| 2021 |
Alizadeh D, Wong RA, Gholamin S, Maker M, Aftabizadeh M, Yang X, Pecoraro JR, Jeppson JD, Wang D, Aguilar B, Starr R, Larmonier CB, Larmonier N, Chen MH, Wu X, et al. IFNg is Critical for CAR T Cell Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discovery. PMID 33837065 DOI: 10.1158/2159-8290.CD-20-1661 |
0.49 |
|
| 2019 |
Rondeau E, Larmonier N, Pradeu T, Bikfalvi A. Characterizing causality in cancer. Elife. 8. PMID 31782731 DOI: 10.7554/eLife.53755 |
0.346 |
|
| 2017 |
Daste A, Domblides C, Gross-Goupil M, Chakiba C, Quivy A, Cochin V, de Mones E, Larmonier N, Soubeyran P, Ravaud A. Immune checkpoint inhibitors and elderly people: A review. European Journal of Cancer (Oxford, England : 1990). 82: 155-166. PMID 28689093 DOI: 10.1016/J.Ejca.2017.05.044 |
0.383 |
|
| 2016 |
Stokes J, Hoffman EA, Zeng Y, Larmonier N, Katsanis E. Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. British Journal of Haematology. PMID 27030315 DOI: 10.1111/Bjh.14034 |
0.301 |
|
| 2016 |
Alizadeh D, Larmonier N. Generation and Expansion of T Helper 17 Lymphocytes Ex Vivo. Methods in Molecular Biology (Clifton, N.J.). 1371: 101-13. PMID 26530797 DOI: 10.1007/978-1-4939-3139-2_7 |
0.451 |
|
| 2015 |
Majeed BA, Eberson LS, Tawinwung S, Larmonier N, Secomb TW, Larson DF. Functional aortic stiffness: role of CD4(+) T lymphocytes. Frontiers in Physiology. 6: 235. PMID 26379554 DOI: 10.3389/Fphys.2015.00235 |
0.307 |
|
| 2015 |
Janikashvili N, Trad M, Gautheron A, Samson M, Lamarthée B, Bonnefoy F, Lemaire-Ewing S, Ciudad M, Rekhviashvili K, Seaphanh F, Gaugler B, Perruche S, Bateman A, Martin L, Audia S, ... ... Larmonier N, et al. Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8(+) T lymphocytes. The Journal of Allergy and Clinical Immunology. 135: 1614-1624.e4. PMID 25630940 DOI: 10.1016/J.Jaci.2014.12.1868 |
0.518 |
|
| 2014 |
Majeed B, Tawinwung S, Eberson LS, Secomb TW, Larmonier N, Larson DF. Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening. International Journal of Hypertension. 2014: 126365. PMID 25258681 DOI: 10.1155/2014/126365 |
0.421 |
|
| 2014 |
Alizadeh D, Larmonier N. Chemotherapeutic targeting of cancer-induced immunosuppressive cells. Cancer Research. 74: 2663-8. PMID 24778417 DOI: 10.1158/0008-5472.Can-14-0301 |
0.554 |
|
| 2014 |
Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15. European Journal of Immunology. 44: 2489-99. PMID 24777831 DOI: 10.1002/Eji.201343803 |
0.405 |
|
| 2014 |
Alizadeh D, Katsanis E, Larmonier N. Chemotherapeutic targeting of myeloid-derived suppressor cells. Oncoimmunology. 3: e27359. PMID 24653963 DOI: 10.4161/Onci.27359 |
0.52 |
|
| 2014 |
Alizadeh D, Trad M, Hanke NT, Larmonier CB, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Research. 74: 104-18. PMID 24197130 DOI: 10.1158/0008-5472.Can-13-1545 |
0.602 |
|
| 2014 |
Alizadeh D, Katsanis E, Larmonier N. Abstract 150: Role of reactive oxygen species in doxorubicin-induced apoptosis of myeloid-derived suppressor cells Cancer Research. 74: 150-150. DOI: 10.1158/1538-7445.Am2014-150 |
0.569 |
|
| 2013 |
Alizadeh D, Katsanis E, Larmonier N. The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer. Clinical & Developmental Immunology. 2013: 957878. PMID 24454480 DOI: 10.1155/2013/957878 |
0.541 |
|
| 2013 |
Audia S, Samson M, Mahévas M, Ferrand C, Trad M, Ciudad M, Gautheron A, Seaphanh F, Leguy V, Berthier S, Salles B, Martin L, Lorcerie B, Ortega-Deballon P, Facy O, ... ... Larmonier N, et al. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia. Blood. 122: 2477-86. PMID 23963041 DOI: 10.1182/Blood-2013-03-491415 |
0.479 |
|
| 2013 |
Hanke N, Alizadeh D, Katsanis E, Larmonier N. Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy. Critical Reviews in Immunology. 33: 1-21. PMID 23510023 DOI: 10.1615/Critrevimmunol.2013006679 |
0.589 |
|
| 2013 |
Alizadeh D, Trad M, Katsanis E, Larmonier N. Abstract 4740: Doxorubicin eliminates tumor-induced myeloid-derived suppressor cells and enhances T-helper lymphocyte-based immunotherapy in a murine breast cancer model. Cancer Research. 73: 4740-4740. DOI: 10.1158/1538-7445.Am2013-4740 |
0.603 |
|
| 2012 |
Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, Kartchner J, Janikashvili N, Bonnotte B, Larmonier N, Katsanis E. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. Journal of Leukocyte Biology. 92: 987-97. PMID 22891289 DOI: 10.1189/Jlb.0911465 |
0.525 |
|
| 2012 |
Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, Manckoundia P, Maillefert JF, Besancenot JF, Aho-Glele S, Olsson NO, ... ... Larmonier N, et al. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis and Rheumatism. 64: 3788-98. PMID 22833233 DOI: 10.1002/Art.34647 |
0.48 |
|
| 2012 |
Larmonier N, Bonnotte B, Katsanis E. Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells. Oncoimmunology. 1: 566-568. PMID 22754789 DOI: 10.4161/Onci.19370 |
0.545 |
|
| 2011 |
Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clinical & Developmental Immunology. 2011: 430394. PMID 22110524 DOI: 10.1155/2011/430394 |
0.603 |
|
| 2011 |
LaCasse CJ, Janikashvili N, Larmonier CB, Alizadeh D, Hanke N, Kartchner J, Situ E, Centuori S, Har-Noy M, Bonnotte B, Katsanis E, Larmonier N. Th-1 lymphocytes induce dendritic cell tumor killing activity by an IFN-γ-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 187: 6310-7. PMID 22075702 DOI: 10.4049/Jimmunol.1101812 |
0.592 |
|
| 2011 |
Audia S, Samson M, Guy J, Janikashvili N, Fraszczak J, Trad M, Ciudad M, Leguy V, Berthier S, Petrella T, Aho-Glélé S, Martin L, Maynadié M, Lorcerie B, Rat P, ... ... Larmonier N, et al. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood. 118: 4394-400. PMID 21876120 DOI: 10.1182/Blood-2011-03-344051 |
0.465 |
|
| 2011 |
Lakomy D, Janikashvili N, Fraszczak J, Trad M, Audia S, Samson M, Ciudad M, Vinit J, Vergely C, Caillot D, Foucher P, Lagrost L, Chouaib S, Katsanis E, Larmonier N, et al. Cytotoxic dendritic cells generated from cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 187: 2775-82. PMID 21804019 DOI: 10.4049/Jimmunol.1004146 |
0.543 |
|
| 2011 |
Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S, Bonnotte B, Har-Noy M, Larmonier N, Katsanis E. Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia. Blood. 117: 1555-64. PMID 21123824 DOI: 10.1182/Blood-2010-06-288621 |
0.589 |
|
| 2011 |
Larmonier CB, Midura-Kiela MT, Ramalingam R, Laubitz D, Janikashvili N, Larmonier N, Ghishan FK, Kiela PR. Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease Inflammatory Bowel Diseases. 17: 503-515. PMID 20629184 DOI: 10.1002/Ibd.21391 |
0.335 |
|
| 2010 |
Ordaz ML, Larmonier N, Lybarger L. DC-expressed MHC class I single-chain trimer-based vaccines prime cytotoxic T lymphocytes against exogenous but not endogenous antigens. Cellular Immunology. 262: 141-9. PMID 20199770 DOI: 10.1016/J.Cellimm.2010.02.006 |
0.42 |
|
| 2010 |
Janikashvili N, Larmonier N, Katsanis E. Personalized dendritic cell-based tumor immunotherapy. Immunotherapy. 2: 57-68. PMID 20161666 DOI: 10.2217/Imt.09.78 |
0.49 |
|
| 2010 |
Fraszczak J, Trad M, Janikashvili N, Cathelin D, Lakomy D, Granci V, Morizot A, Audia S, Micheau O, Lagrost L, Katsanis E, Solary E, Larmonier N, Bonnotte B. Peroxynitrite-dependent killing of cancer cells and presentation of released tumor antigens by activated dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 1876-84. PMID 20089706 DOI: 10.4049/Jimmunol.0900831 |
0.579 |
|
| 2010 |
Cantrell J, Larmonier C, Janikashvili N, Bustamante S, Fraszczak J, Herrell A, Lundeen T, J LaCasse C, Situ E, Larmonier N, Katsanis E. Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells. Immunobiology. 215: 535-44. PMID 19880213 DOI: 10.1016/J.Imbio.2009.09.006 |
0.561 |
|
| 2010 |
Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunology, Immunotherapy : Cii. 59: 1-11. PMID 19618185 DOI: 10.1007/S00262-009-0736-1 |
0.6 |
|
| 2009 |
Chen X, Zhang M, Zhu X, Deng Q, Liu H, Larmonier N, Graner MW, Zhou B. Engagement of Toll-like receptor 2 on CD4(+) T cells facilitates local immune responses in patients with tuberculous pleurisy. The Journal of Infectious Diseases. 200: 399-408. PMID 19552525 DOI: 10.1086/600075 |
0.451 |
|
| 2008 |
Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. Journal of Immunology (Baltimore, Md. : 1950). 181: 6955-63. PMID 18981115 DOI: 10.4049/Jimmunol.181.10.6955 |
0.555 |
|
| 2008 |
Li G, Andreansky S, Helguera G, Sepassi M, Janikashvili N, Cantrell J, Lacasse CL, Larmonier N, Penichet ML, Katsanis E. A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model. Molecular Cancer Therapeutics. 7: 721-9. PMID 18347157 DOI: 10.1158/1535-7163.Mct-07-2067 |
0.54 |
|
| 2008 |
Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E. Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. Journal of Leukocyte Biology. 83: 1049-59. PMID 18174364 DOI: 10.1189/Jlb.0907635 |
0.596 |
|
| 2007 |
Audia S, Nicolas A, Cathelin D, Larmonier N, Ferrand C, Foucher P, Fanton A, Bergoin E, Maynadie M, Arnould L, Bateman A, Lorcerie B, Solary E, Chauffert B, Bonnotte B. Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes. Clinical and Experimental Immunology. 150: 523-30. PMID 17956583 DOI: 10.1111/J.1365-2249.2007.03521.X |
0.453 |
|
| 2007 |
Nicolas A, Cathelin D, Larmonier N, Fraszczak J, Puig PE, Bouchot A, Bateman A, Solary E, Bonnotte B. Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 179: 812-8. PMID 17617571 DOI: 10.4049/Jimmunol.179.2.812 |
0.561 |
|
| 2007 |
Larmonier N, Cathelin D, Larmonier C, Nicolas A, Merino D, Janikashvili N, Audia S, Bateman A, Thompson J, Kottke T, Hartung T, Katsanis E, Vile R, Bonnotte B. The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat model. Experimental Cell Research. 313: 2345-55. PMID 17466973 DOI: 10.1016/J.Yexcr.2007.03.027 |
0.436 |
|
| 2007 |
Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro. Clinical and Experimental Immunology. 148: 136-45. PMID 17349014 DOI: 10.1111/J.1365-2249.2007.03323.X |
0.458 |
|
| 2007 |
Chen X, Zhou B, Li M, Deng Q, Wu X, Le X, Wu C, Larmonier N, Zhang W, Zhang H, Wang H, Katsanis E. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clinical Immunology (Orlando, Fla.). 123: 50-9. PMID 17234458 DOI: 10.1016/J.Clim.2006.11.009 |
0.434 |
|
| 2007 |
Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunology, Immunotherapy : Cii. 56: 48-59. PMID 16612596 DOI: 10.1007/S00262-006-0160-8 |
0.49 |
|
| 2006 |
Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S, Katsanis E. Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. International Journal of Cancer. Journal International Du Cancer. 119: 2624-31. PMID 16989012 DOI: 10.1002/Ijc.22150 |
0.557 |
|
| 2006 |
Larmonier N, Mérino D, Nicolas A, Cathelin D, Besson A, Bateman A, Solary E, Martin F, Katsanis E, Bonnotte B. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading. Apoptosis : An International Journal On Programmed Cell Death. 11: 1513-24. PMID 16738802 DOI: 10.1007/S10495-006-8765-0 |
0.564 |
|
| 2006 |
Chen X, Zeng Y, Li G, Larmonier N, Graner MW, Katsanis E. Peritransplantation vaccination with chaperone-rich cell lysate induces antileukemia immunity. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 275-83. PMID 16503496 DOI: 10.1016/J.Bbmt.2006.01.001 |
0.516 |
|
| 2004 |
Bonnotte B, Crittenden M, Larmonier N, Gough M, Vile RG. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 173: 4929-35. PMID 15470034 DOI: 10.4049/Jimmunol.173.8.4929 |
0.489 |
|
| 2004 |
Ghiringhelli F, Larmonier N, Schmitt E, Parcellier A, Cathelin D, Garrido C, Chauffert B, Solary E, Bonnotte B, Martin F. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. European Journal of Immunology. 34: 336-44. PMID 14768038 DOI: 10.1002/Eji.200324181 |
0.577 |
|
| 2004 |
Larmonier CB, Arnould L, Larmonier N, Baumann S, Moutet M, Saint-Giorgio V, Pance A, Jeannin JF. Kinetics of tumor cell apoptosis and immune cell activation during the regression of tumors induced by lipid A in a rat model of colon cancer. International Journal of Molecular Medicine. 13: 355-61. PMID 14767564 DOI: 10.3892/Ijmm.13.3.355 |
0.572 |
|
| 2003 |
Larmonier N, Ghiringhelli F, Larmonier CB, Moutet M, Fromentin A, Baulot E, Solary E, Bonnotte B, Martin F. Freshly isolated bone marrow cells induce death of various carcinoma cell lines. International Journal of Cancer. 107: 747-56. PMID 14566824 DOI: 10.1002/Ijc.11463 |
0.435 |
|
| 2002 |
Larmonier N, Billerey C, Rébé C, Parcellier A, Moutet M, Fromentin A, Kroemer G, Garrido C, Solary E, Martin F, Bonnotte B. An atypical caspase-independent death pathway for an immunogenic cancer cell line. Oncogene. 21: 6091-100. PMID 12203121 DOI: 10.1038/Sj.Onc.1205738 |
0.418 |
|
| 2001 |
Gurbuxani S, Bruey JM, Fromentin A, Larmonier N, Parcellier A, Jäättelä M, Martin F, Solary E, Garrido C. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene. 20: 7478-7485. PMID 11709719 DOI: 10.1038/Sj.Onc.1204948 |
0.495 |
|
| 2001 |
Bonnotte B, Larmonier N, Favre N, Fromentin A, Moutet M, Martin M, Gurbuxani S, Solary E, Chauffert B, Martin F. Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System Journal of Immunology. 167: 5077-5083. PMID 11673517 DOI: 10.4049/Jimmunol.167.9.5077 |
0.539 |
|
| Show low-probability matches. |